Stock & Company Details
Clene Inc $CLNN
Price:
N/A
N/A
13M
$55M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.22
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CLNN technical indicators
Latest Clene Inc (CLNN) indicator readings as of 2026-10-09.
CLNN's 14-day RSI is 42.3, in neutral territory. At $3.86 it is trading 27.9% below its 200-day moving average of $5.35, and below its 50-day average of $4.26. Price sits in the middle of its Bollinger Bands ($3.54 to $4.58). ADX reads 13.1, indicating a range-bound market rather than a trend.
Overview
Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland.
Finance Bot
Ask your questions
Start by typing a question below.
